SCANCELL HOLDINGS PLC
Secondary Market



Scancell Holdings plc is the parent company of Scancell Limited and acts purely as a holding company. Scancell is developing a pipeline of cancer vaccines based on its patented ImmunoBody (TM) platform which has the potential to overcome the significant limitations of existing approaches. Scancell also has the potential to generate significant revenues from licensing the technology on a target by target basis to other companies involved in the discovery and development of therapeutic vaccines. With outstanding 'proof of concept' in vivo data in place, the Company wants to take the lead melanoma vaccine, SCIB1, through a Phase I/IIa clinical trial with completion in 2012.

SCANCELL HOLDINGS PLC

Symbol Ccy Code Bid (GBX) Ask Mid Previous Close Volume Last Traded 52Wk Low 52Wk High
SCLP.GB GBX 13.7 14.7 14.2 14.2 5,644 24/05/2018 8.6 19.44
All data delayed by up to 5 minutes
MIFID II compliant post-trade transaction data is available here. The data is delayed by at least 15 minutes and will be refreshed every 30 minutes.

Shareholder Documents

Please see primary market for this information

Reports & Accounts

Please see primary market for this information

Board

Company Secretary Mr Nigel Evans.
Director Dr Elisabeth Adams
Director Ms Kate Bowden-Cornish
Director Dr John Chiplin
Director Prof Linda Durrant
Director Dr Matthew Frohn
Director Dr Richard Goodfellow
Non-Executive Chairman Mr David Evans.
Non-Executive Director Mr Michael Rippon.

Business Address

City Hospital, Nottingham, NG5 1PB.,

Business Telephone: 0115 823 1863

Business Email:

Registered Address

, , ,

Registrar : SLC Registrars Ltd

Ashley Park House, 42-50 Hersham Road, Walton-on-Thames, Surrey, United Kingdom, KT12 1RZ

Phone:01372 467308
Email slc@davidvenus.com

Key Information

ISIN: GB00B63D3314
Symbol: SCLP.GB
MiFID Status: Regulated Market
  Please see primary market for more information

Latest Trades

Date & Time Volume Price
24/05/2018 09:52 5,644 14.42
23/05/2018 12:50 863 14.47
23/05/2018 10:40 3,600 14.1
23/05/2018 10:17 5,156 14.1
23/05/2018 09:43 20,000 14.3
View latest trades

Contacts


Board

Company Secretary Mr Nigel Evans.
Director Dr Elisabeth Adams
Director Ms Kate Bowden-Cornish
Director Dr John Chiplin
Director Prof Linda Durrant
Director Dr Matthew Frohn
Director Dr Richard Goodfellow
Non-Executive Chairman Mr David Evans.
Non-Executive Director Mr Michael Rippon.

Business Address

City Hospital, Nottingham, NG5 1PB.,

Business Telephone: 0115 823 1863

Business Email:

Registered Address

, , ,

Registrar : SLC Registrars Ltd

Ashley Park House, 42-50 Hersham Road, Walton-on-Thames, Surrey, United Kingdom, KT12 1RZ

Phone:01372 467308
Email slc@davidvenus.com